TIM
ELV icon

Timelo Investment Management’s Elevance Health ELV Stock Holding History

Timelo Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
5,000
-2,000
-29% -$742K 0.55% 21
2026
Q1 		$2.05M Sell
7,000
-9,000
-56% -$2.96M 1.62% 18
2025
Q4 		$5.61M Buy
16,000
+2,000
+14% +$676K 1.99% 5
2025
Q3 		$4.25M Buy
+14,000
New +$4.35M 1.59% 5

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Timelo Investment Management's ELV Position: Q2 2026 in Review

Timelo Investment Management reduced its Elevance Health (ELV) stake by 29% in Q2 2026, selling an estimated $742K and leaving 5,000 shares worth $1.93M. The position accounts for 0.55% of the portfolio, ranked #21.

Timelo Investment Management first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.61M in Q4 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Timelo Investment Management held 5,000 shares of Elevance Health worth $1.93M as of Q2 2026.
  • Timelo Investment Management sold 2,000 Elevance Health shares in Q2 2026, an estimated $742K.
  • Elevance Health made up 0.55% of Timelo Investment Management's portfolio in Q2 2026, its #21 holding.
  • Timelo Investment Management first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • Timelo Investment Management's Elevance Health position peaked at $5.61M in Q4 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Timelo Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.